SCHEMBL6539353

SCHEMBL6539353

CCOC(=O)c1ccccc1NC(=O)Nc1ccc(C[C@@H](CO[Si](C)(C)C)N(C[C@H](O)COc2ccccc2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 9/20 0.42
ADRB3 P13945 9/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPK10 P53779 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PPIA P62937 1/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
KMT2A Q03164 1/20 0.38
BACE1 P56817 1/20 0.37
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539595 0.92 MAPT (0.48) ADRB1ADRB3ALDH1A1TDP1SMN1; SMN2
SCHEMBL6538469 0.88 MEN1 (0.47) ADRB1ADRB3CA12CA1CA2
SCHEMBL6539067 0.79 ADRB1 (0.49) ADRB1ADRB3BACE1
SCHEMBL6539522 0.77 ADRB1 (0.52) ADRB1ADRB3MAPTMEN1KMT2A
SCHEMBL6539338 0.77 ADRB1 (0.39) ADRB1ADRB3ALDH1A1MAPK1SMN1; SMN2
SCHEMBL6539352 0.74 ADRB1 (0.62) ADRB1ADRB3SMN1; SMN2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6538740 0.72 ADRB3 (0.68) ADRB1ADRB3CA12CA1CA2
SCHEMBL6540414 0.72 ADRB1 (0.53) ADRB1ADRB3SMN1; SMN2MEN1KMT2A
SCHEMBL6539708 0.70 ADRB3 (0.36) ADRB3BACE1
SCHEMBL6539288 0.70 ADRB1 (0.44) ADRB1ADRB3MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed
WO-2002024635-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-28 WO disclosed